Bel Marra Health Reports on New Benefits of Aspirin for Cancer Prevention
Toronto, ON (PRWEB) September 17, 2014 -- Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, has reported on new research which has outlined a potential use for aspirin: Cancer prevention.
As Bel Marra Health reports in its article, (http://www.belmarrahealth.com/cancer/the-one-daily-pill-that-fights-deadly-illness/), a new study indicates that long-term aspirin therapy may provide a strategy to protect against cancers of the digestive tract.
The research findings, published in Annals of Oncology, showed that taking aspirin, also known as acetlylsalicylic acid or ASA, in daily low doses – often just one pill a day - could significantly reduce the risk of developing stomach and bowel cancers, as well as cancer of the esophagus.
A research team from the Center for Cancer Prevention at the Queen Mary University of London performed a meta-analysis of previous studies investigating the benefits and harms of aspirin use.
Based on the team’s findings, the researchers say bowel cancer cases could be reduced by 35 percent (deaths by 40 percent) and stomach and esophageal cancer cases could be reduced by 30 percent (deaths by 35 to 50 percent) if adults aged 50 to 65 took a 75 mg to 100 mg dose of aspirin each day for five to 10 years. Aspirin comes in a variety of dosages over-the-counter, ranging from 30 mg to 400 mg, sometimes more.
According to the published findings in the Annals of Oncology, the effects of aspirin on cancer didn’t take effect until three years into treatment, but the benefits lasted when aspirin was used long-term. There was no connection when dosage was examined; individuals using low and standard dosages saw the same benefits.
The results add to the list of demonstrated benefits of daily aspirin therapy, which also include its help as an antiplatelet for those at high risk of stroke or heart attack. In prior studies, aspirin has shown preventative effects against ovarian, prostate and breast cancers, as well as some skin cancers, the American Cancer Society reports.
Study authors acknowledge there is a well-known risk factor of aspirin - excess internal bleeding. But they say the benefits appear to outweigh the risk as long as the correct dosage isn’t exceeded. Over a 15-year period, individuals in the study group saw a 4 percent reduction in all deaths.
Spokesperson for Bel Marra Health Dr. Victor Marchione says, “This recent development doesn’t mean that you should take more than a recommended dose of aspirin, or continue with poor lifestyle habits. That little pill won’t wave away the harm of smoking, drinking and obesity which all contribute to cancer risk.”
No public health organizations, including the American Cancer Society, recommend taking aspirin as a sole preventative measure for cancer or any other illness.
(SOURCE: J. Cuzick et al., “Estimates of benefits and harms of prophylactic use of aspirin in the general population,” Annals of Oncology, 2014; retrieved from: http://annonc.oxfordjournals.org/content/early/2014/07/30/annonc.mdu225.abstract)
Bel Marra Health is the maker of Heart Rescue, a high-quality nutritional supplement to help support and maintain heart health. All ingredients are backed with scientific evidence. Every product is tested for safety, quality and purity at every stage of the manufacturing process.
Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities to ensure that our health-conscious customers are getting top-quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.
Managing Editor, Bel Marra Health, http://www.belmarrahealth.com/, +1 905-851-9966 Ext: 231, [email protected]
Share this article